Gravar-mail: IMMU-30. UTILIZING A NOVEL MASS CYTOMETRY-BASED IMMUNOMONITORING PLATFORM FOR THE CHARACTERIZATION OF VACCINE-REACTIVE, EPITOPE-SPECIFIC CD8(+) T-CELLS IN HLA-A*0201(+) PATIENTS WITH K27M(+) DIFFUSE MIDLINE GLIOMAS